Cargando…

Clinical value of (18)F-FDG PET/CT in the management of HIV-associated lymphoma

HIV is still a major public health problem. At present, HIV-associated lymphoma remains the leading cause of deaths among people living with HIV, which should be paid more attention to. (18)F-fluorodeoxglucose (FDG) PET/CT has been recommended in the initial staging, restaging, response assessment a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Qi, Yang, Tao, Chen, Xiaoliang, Liu, Yao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909962/ https://www.ncbi.nlm.nih.gov/pubmed/36776334 http://dx.doi.org/10.3389/fonc.2023.1117064

Ejemplares similares

Role of 18F-FDG PET/CT in patients affected by pulmonary primary lymphoma
por: Peng, Ying, et al.
Publicado: (2022)

Prognostic Value of Heterogeneity Index Derived from Baseline (18)F-FDG PET/CT in Mantle Cell Lymphoma
por: Liu, Fei, et al.
Publicado: (2022)

Prognostic values of ALDOB expression and (18)F-FDG PET/CT in hepatocellular carcinoma
por: Jia, Wenzhi, et al.
Publicado: (2022)

Tailoring the clinical management of colorectal cancer by (18)F-FDG PET/CT
por: Shi, Yang, et al.
Publicado: (2022)

Comparison of Nasopharyngeal MR, (18) F-FDG PET/CT, and (18) F-FDG PET/MR for Local Detection of Natural Killer/T-Cell Lymphoma, Nasal Type
por: Guo, Rui, et al.
Publicado: (2020)

Case report: Low-grade myofibroblastic sarcoma resembling lymphoma on (18)F-FDG PET/CT
por: Zhang, Huan, et al.
Publicado: (2023)

Measurement Repeatability of (18)F-FDG PET/CT Versus (18)F-FDG PET/MRI in Solid Tumors of the Pelvis
por: Fraum, Tyler J., et al.
Publicado: (2019)

The Clinical Accuracy and Risk Stratification in End of Therapy (18)F-FDG PET/CT in Burkitt Lymphoma
por: Mo, Yi Wen, et al.
Publicado: (2021)

Prediction of prognosis and pathologic grade in follicular lymphoma using (18)F-FDG PET/CT
por: Li, Hongyan, et al.
Publicado: (2022)

Value of (18)F-FDG PET/MRI in the Preoperative Assessment of Resectable Esophageal Squamous Cell Carcinoma: A Comparison With (18)F-FDG PET/CT, MRI, and Contrast-Enhanced CT
por: Wang, Fei, et al.
Publicado: (2022)

The Role of the Metabolic Parameters of (18)F-FDG PET/CT in Patients With Locally Advanced Cervical Cancer
por: Wang, Dunhuang, et al.
Publicado: (2021)

Peritoneal Mouse as Detected on (18)F-FDG PET-CT
por: Allam, Talha, et al.
Publicado: (2013)

Active Shingles Infection as Detected on (18)F-FDG PET/CT
por: Muzaffar, Razi, et al.
Publicado: (2013)

Pediatric Nasopharyngeal Carcinoma as Seen on 18F-FDG PET/CT
por: Muzaffar, Razi, et al.
Publicado: (2019)

Impact of Renal Failure on F18-FDG PET/CT Scans
por: Kode, Vishwajit, et al.
Publicado: (2017)

Skeletal Metastasis as Detected by 18F-FDG PET with Negative CT of the PET/CT: Frequency and Impact on Cancer Staging and/or Management
por: Ahmed, Fatma, et al.
Publicado: (2016)

The Incremental Added Value of Including the Head in (18)F-FDG PET/CT Imaging for Cancer Patients
por: Abdelmalik, Amir G., et al.
Publicado: (2013)

Meta-analysis of the diagnostic value of (18)F-FDG PET/CT in the recurrence of epithelial ovarian cancer
por: Wang, Xiaoyan, et al.
Publicado: (2022)

[18F]FDG PET/CT versus [18F]FDG PET/MRI for the diagnosis of colorectal liver metastasis: A systematic review and meta-analysis
por: Miao, Zhi, et al.
Publicado: (2023)

The Evolving Role of (18)F-FDG PET/CT in Diagnosis and Prognosis Prediction in Progressive Prostate Cancer
por: Shen, Kai, et al.
Publicado: (2021)

Association Between (18)F-FDG PET/CT-Based SUV Index and Malignant Status of Persistent Ground-Glass Nodules
por: Niu, Rong, et al.
Publicado: (2021)

Diagnostic value of [(68)Ga]Ga-FAPI-04 in patients with colorectal cancer in comparison with [(18)F]F-FDG PET/CT
por: Lin, Xinfeng, et al.
Publicado: (2023)

(18)F-FDG PET-CT for Surveillance of Brazilian Patients with Li-Fraumeni Syndrome
por: Nogueira, Sonia Tereza Santos, et al.
Publicado: (2015)

A preliminary investigation of the relationship between (18)F-FDG PET/CT metabolic parameters and prognosis in angioimmunoblastic T-cell lymphoma
por: Hu, Lanping, et al.
Publicado: (2023)

Frontiers and hotspots of (18)F-FDG PET/CT radiomics: A bibliometric analysis of the published literature
por: Liu, Xinghai, et al.
Publicado: (2022)

Diagnostic performance of integrated whole-body (18)F-FDG PET/MRI for detecting bone marrow involvement in indolent lymphoma: Comparison with (18)F-FDG PET or MRI alone
por: Chen, Xuetao, et al.
Publicado: (2023)

The Incremental Prognostic Value of Baseline (18)F-FDG PET/CT Imaging in Angioimmunoblastic T-Cell Lymphoma
por: Wang, Hui, et al.
Publicado: (2020)

(68)Ga-FAPI-04 Versus (18)F-FDG PET/CT in the Detection of Hepatocellular Carcinoma
por: Wang, Hao, et al.
Publicado: (2021)

Intra-Individual Comparison of 18F-PSMA-1007 and 18F-FDG PET/CT in the Evaluation of Patients With Prostate Cancer
por: Zhou, Xing, et al.
Publicado: (2021)

Value of preoperative (18)F-FDG PET/CT and HRCT in predicting the differentiation degree of lung adenocarcinoma dominated by solid density
por: Chen, Xiaolin, et al.
Publicado: (2023)

Prognostic value of [18F]-FDG PET/CT in patients with meta-static breast cancer treated with cyclin-dependent inhibitors
por: Annovazzi, Alessio, et al.
Publicado: (2023)

Prognostic Values of Baseline (18)F-FDG PET/CT in Patients with Peripheral T-Cell Lymphoma
por: Zhou, Yeye, et al.
Publicado: (2020)

The role of (18)F-FDG PET/CT in patients with synchronous multiple primary malignant neoplasms occurring at the same time
por: Luo, Zhe Huang, et al.
Publicado: (2022)

Report of Eleven Patients of Subcutaneous Panniculitis-Like T-Cell Lymphoma: Clinicopathologic Features, (18)F-FDG PET/CT Findings and Outcome
por: Jiang, Maoqing, et al.
Publicado: (2021)

The Role of 18F-FDG PET/CT in Guiding Precision Medicine for Invasive Bladder Carcinoma
por: Girard, Antoine, et al.
Publicado: (2020)

The Value of (18)F-FDG PET/CT and Abdominal PET/MRI as a One-Stop Protocol in Patients With Potentially Resectable Colorectal Liver Metastases
por: Zhou, Nina, et al.
Publicado: (2021)

Prediction value of (18)F-FDG PET/CT intratumor metabolic heterogeneity parameters for recurrence after radical surgery of stage II/III colorectal cancer
por: Liu, Xin, et al.
Publicado: (2022)

Predictive value of intratumoral-metabolic heterogeneity derived from (18)F-FDG PET/CT in distinguishing microsatellite instability status of colorectal carcinoma
por: Zhang, Li, et al.
Publicado: (2023)

Prognostic prediction by (18)F-FDG-PET/CT parameters in patients with neuroblastoma: a systematic review and meta-analysis
por: Hu, Ruimin, et al.
Publicado: (2023)

Comparing the diagnostic value of 18F-FDG PET/CT scan and bone marrow biopsy in newly diagnosed pediatric neuroblastoma and ganglioneuroblastoma
por: Fu, Zheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_asakc98u4uln6j6cj7putuotlb